Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55.6M
-
Number of holders
-
179
-
Total 13F shares, excl. options
-
65.9M
-
Shares change
-
-722K
-
Total reported value, excl. options
-
$8.05B
-
Value change
-
-$71.1M
-
Put/Call ratio
-
0.21
-
Number of buys
-
89
-
Number of sells
-
-86
-
Price
-
$122.13
Significant Holders of Ascendis Pharma A/S - ADR (ASND) as of Q4 2022
222 filings reported holding ASND - Ascendis Pharma A/S - ADR as of Q4 2022.
Ascendis Pharma A/S - ADR (ASND) has 179 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 65.9M shares
.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (6.96M shares), Artisan Partners Limited Partnership (6.92M shares), FMR LLC (5.23M shares), BAKER BROS. ADVISORS LP (4.95M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.71M shares), JANUS HENDERSON GROUP PLC (3.64M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (3.16M shares), Avoro Capital Advisors LLC (3.1M shares), WELLINGTON MANAGEMENT GROUP LLP (3.05M shares), and T. Rowe Price Investment Management, Inc. (2.83M shares).
This table shows the top 179 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.